Dried Blood Spot Collection Cards Market Size & Growth Forecast 2026–2035, By Segments (End Use, Card Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Dried Blood Spot Collection Cards Market size stood at USD 411.29 Million in 2025 and is predicted to grow at a 4.8% CAGR from 2026 to 2035, reaching USD 657.3 Million by 2035. The industry revenue for 2026 is estimated at USD 428.32 million.

• Base Year Value (2025): USD 411.29 Million
• CAGR (2026-2035): 4.8%
• Forecast Year Value (2035): USD 657.3 Million
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Dried Blood Spot Collection Cards Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 37.13% market share in 2025, driven by established laboratory workflows, widespread newborn screening programs, and standardized specimen collection practices across clinical and research settings.
  • Asia Pacific is expected to grow at a 5.47% CAGR due to expanding adoption of accessible diagnostic sampling, decentralized testing, and cost-effective collection methods across developing healthcare systems.

• Segment Momentum:

  • Whatman 903 held the largest 2025 market share at 43% due to its established use in routine testing programs, consistent sample collection performance, and compatibility with standard laboratory workflows.
  • Diagnostics centers are expanding fastest because their high-throughput testing, standardized workflows, and efficient sample processing align well with dried blood spot collection methods, supporting greater operational scalability.

• Market Expansion Drivers:

  • Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods.
  • Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies.
  • Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions.

• Leading Market Participants:

  Key players in the dried blood spot collection cards market include F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Germany), PerkinElmer Inc. (United States), Shimadzu Corporation (Japan), Ahlstrom-Munksjö Oyj (Finland), Pall Corporation (United States), Cytiva (United States), Eastern Business Forms, Inc. (United States), Archimed Life Science GmbH (Germany).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 411.29 Million
  • Projected Market Size: USD 657.3 Million by 2035
  • Growth Forecasts: 4.8% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals & Clinics (End Use) | Whatman 903 (Card Type) | New Born Screening (NBS) (Application)
  • Emerging Opportunity Segment: Diagnostics Centers (End Use) | FTA (Card Type) | Forensics (Application)

Market Growth Drivers and Industry Trends

Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods

As newborn screening programs broaden the number of conditions tested and extend coverage through public health systems, procurement increasingly favors collection formats that fit high-throughput, standardized workflows. The dried blood spot collection cards market benefits from This trend because these cards simplify heel-prick sample collection, drying, transport, and laboratory handling while supporting consistent specimen quality at scale. Program administrators and hospital networks tend to prioritize tools that reduce logistical friction between maternity wards, regional collection centers, and centralized screening laboratories, which is reinforcing routine card usage and aiding market expansion in regulated neonatal testing pathways.

Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies

Expanded infectious disease surveillance and screening efforts are influencing testing models toward decentralized and more accessible sample collection, especially where venous draws are impractical or laboratory infrastructure is uneven. In that setting, the dried blood spot collection cards market gains traction because low-volume capillary sampling allows easier field collection, safer transport, and storage without the same handling burden associated with liquid blood specimens. Public health agencies, diagnostic providers, and outreach programs increasingly adopt workflows built around simplified sample capture, increasing demand for collection cards that fit large-scale screening, epidemiological monitoring, and follow-up testing in dispersed populations.

Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions

The spread of forensic casework outside major laboratory hubs and the rise of remote diagnostic services are increasing the value of sample collection formats that preserve integrity during transport and delayed analysis. The dried blood spot collection cards market is being strengthened by this requirement, as investigators and healthcare providers need compact, portable tools that enable reliable blood collection in homes, field locations, and low-access settings without immediate cold-chain support. This practical advantage shapes purchasing decisions around evidence handling, chain-of-custody workflows, and remote testing operations, contributing to market size growth where mobility and storage stability are operational priorities.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods	2.00%	High	North America, Europe	High	Near Term
Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies	1.80%	High	Asia Pacific, Africa	High	Mid Term
Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions	1.40%	Moderate	Latin America, Asia Pacific	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 37.13% share of the dried blood spot collection cards market. This leadership is sustained by established laboratory testing workflows, broad use of newborn screening and diagnostic sampling programs, and a healthcare infrastructure that supports standardized specimen collection and transport. In practice, the region benefits from consistent adoption across clinical and research settings where dried blood spot methods help simplify sample handling, storage, and shipment, reinforcing steady purchasing activity for collection cards.

Asia Pacific is projected to expand at a 5.47% CAGR over the forecast period in the dried blood spot collection cards market. Growth is being fueled by the wider adoption of accessible diagnostic collection methods across developing healthcare systems, where practical sampling formats are increasingly important for reaching dispersed populations and supporting decentralized testing. The region’s momentum is also tied to rising use of dried blood spot techniques in screening and laboratory networks that need cost-effective sample collection and easier logistics than conventional blood sampling approaches.

Key Country Insights

United States

Clinical Screening Expansion

The U.S. continues to emphasize dried blood spot collection cards for newborn screening, decentralized clinical research, and infectious disease monitoring. Healthcare providers are prioritizing standardized sample collection workflows that integrate efficiently with laboratory automation and expanding diagnostic programs.

Japan

Precision Diagnostic Support

Japan is strengthening the use of dried blood spot collection cards in precision diagnostics and long-term disease monitoring programs. Healthcare institutions are seeking collection products that improve sample integrity while supporting efficient laboratory processing across specialized testing applications.

South Korea

Digital Healthcare Integration

South Korea is incorporating dried blood spot collection cards into expanding digital healthcare and molecular diagnostic services. The country is encouraging convenient sample collection methods that complement remote healthcare delivery and advanced laboratory testing capabilities.

Germany

Laboratory Quality Focus

Germany places strong emphasis on high-quality dried blood spot collection cards that support reliable laboratory diagnostics and validated testing protocols. The market benefits from demand for standardized sampling solutions aligned with clinical research and public health laboratory requirements.

France

Public Health Diagnostics

France continues to utilize dried blood spot collection cards across national screening initiatives and clinical laboratory networks. The market prioritizes dependable sample preservation and standardized collection practices that enhance diagnostic consistency for preventive healthcare programs.

Italy

Specialized Laboratory Adoption

Italy is expanding the application of dried blood spot collection cards within specialized diagnostic laboratories and regional healthcare systems. Healthcare providers are focusing on practical collection solutions that simplify logistics while maintaining analytical performance across diverse testing requirements.

Segment Leadership and Growth Trends

  End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Diagnostics Centers (Fastest-Growing Segment)

Across the dried blood spot collection cards market, Hospitals & Clinics held the strongest position in 2025 with a 70.4% share. Their leadership is underpinned by routine patient access, established sample collection workflows, and the ability to integrate dried blood spot testing into broader clinical care pathways. In practice, hospitals and clinics remain the primary point of contact for screening, follow-up testing, and physician-directed sample collection, which keeps demand concentrated in these settings within the dried blood spot collection cards market.

Diagnostics Centers are emerging as the fastest-growing end-use segment in the dried blood spot collection cards market as testing activity becomes more streamlined and operationally specialized. Their momentum is reinforced through a stronger focus on high-throughput sample handling, standardized testing processes, and efficient turnaround requirements that align well with dried blood spot collection methods. Compared with broader care settings, diagnostics centers are seeing wider adoption because they are better positioned to scale dedicated testing volumes and process samples with greater workflow efficiency.

Card Type Segment Analysis: Whatman 903 (Largest Segment) vs FTA (Fastest-Growing Segment)

In the dried blood spot collection cards market, Whatman 903 accounted for the largest position in 2025 with a 43% share. Its continued leadership reflects entrenched use across established testing programs and familiarity within sample collection and laboratory handling practices. Because consistency in sample capture and compatibility with routine processing are central to everyday operations, buyers in the dried blood spot collection cards market continue to rely on Whatman 903 for standardized use across recurring clinical and diagnostic applications.

FTA is the fastest-growing card type in the dried blood spot collection cards market, driven by increasing demand for collection formats that better support evolving laboratory and sample handling requirements. Its growth is being reinforced by use cases where sample integrity, transport practicality, and downstream processing considerations carry greater weight in purchasing decisions. Relative to more established alternatives, FTA is gaining momentum as end users seek card types that fit more specialized and efficiency-oriented testing workflows.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End Use	Hospitals & Clinics, Diagnostics Centers, Others	Hospitals & Clinics	Diagnostics Centers
Card Type	Whatman 903, Ahlstrom 226, FTA, Others	Whatman 903	FTA
Application	New Born Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, CRO/Research, Others	New Born Screening (NBS)	Forensics

Competitive Landscape and Market Positioning

Top players in the dried blood spot collection cards market:

1. F. Hoffmann-La Roche Ltd (Switzerland)

2. QIAGEN N.V. (Germany)

3. PerkinElmer Inc. (United States)

4. Shimadzu Corporation (Japan)

5. Ahlstrom-Munksjö Oyj (Finland)

6. Pall Corporation (United States)

7. Cytiva (United States)

8. Eastern Business Forms Inc. (United States)

9. Archimed Life Science GmbH (Germany)

The dried blood spot collection cards market is being shaped by the increasing need for convenient sample collection, remote diagnostics, and efficient disease screening programs. Manufacturers are focusing on improved sample preservation technologies, contamination control, and regulatory-compliant materials to enhance testing reliability. Advancements in decentralized healthcare and laboratory automation are also supporting innovation within the dried blood spot collection cards market.

Industry Development/News

Company Name	Date	Key Development
Capitainer	Jan-24	Capitainer launched miQro Lab Solutions, a U.S.-based laboratory in Rhode Island, to accelerate integration of its self-sampling and micro-sampling technologies into the U.S. healthcare system. The initiative is positioned to support broader adoption of decentralized blood collection solutions and improve clinical accessibility and operational efficiency.
Neoteryx (Trajan Scientific)	Sep-22	Neoteryx, part of Trajan Scientific, launched a program supporting micro-sampling pilot studies by providing Mitra devices to healthcare and research organizations. The initiative enables evaluation of remote blood sampling feasibility across clinical and research environments, supporting adoption of decentralized sample collection methods.
Capitainer	Sep-22	Capitainer reported positive performance results for its qDBS volumetric dried blood spot card, demonstrating accurate diagnostic outcomes for phenylketonuria. The technology addresses limitations of conventional DBS cards by improving volume consistency and reducing variability caused by hematocrit effects, strengthening reliability in remote blood sampling applications.